Amryt Pharma plc (AMYT) | Financial Analysis & Statements
Amryt Pharma plc Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
No financial overview data available.
Amryt Pharma plc Income Statement
No income statement data available.
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Amryt Pharma plc Balance Sheet
No balance sheet data available.
Amryt Pharma plc Cash Flow Statement
No cash flow data available.
Amryt Pharma plc Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
39.73
Forward P/E
-490.00
Price to Book
2.80
Price to Sales
4.24
PEG Ratio
-0.39
Profitability Ratios
Profit Margin
52.32%
Operating Margin
-0.86%
Return on Equity
-94.18%
Return on Assets
-2.32%
Financial Health
Current Ratio
1.64
Debt to Equity
164.32
Per Share Data
EPS (TTM)
$0.02
Book Value per Share
$0.02
Revenue per Share
$4.72
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| AMYT | 942.8M | 39.73 | 2.80 | -94.18% | 52.32% | 164.32 |
| AcelRx | 12.2M | 0.14 | - | -130.43% | 0.00% | 0.00 |
| Eli Lilly and | 821.3B | 40.09 | 31.01 | 101.16% | 31.67% | 165.31 |
| Johnson & Johnson | 555.8B | 20.49 | 6.68 | 32.87% | 21.83% | 60.50 |
| AbbVie | 351.5B | 83.46 | -108.79 | 6,225.00% | 6.91% | -21.19 |
| UnitedHealth | 322.3B | 26.81 | 3.42 | 12.18% | 2.68% | 73.98 |
Financial data is updated regularly. All figures are in the company's reporting currency.